Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 06:03 am Purchase |
2020-12-31 | 13G | Athira Pharma, Inc. ATHA |
KAWAS LEEN | 1,693,102 5.200% |
1,693,102 (New Position) |
Filing History |
| 2021-02-12 7:55 pm Unchanged |
2020-12-31 | 13G | Athira Pharma, Inc. ATHA |
VIKING GLOBAL INVESTORS LP | 2,120,653 6.000% |
0 (Unchanged) |
Filing History |
| 2021-02-12 09:31 am Purchase |
2020-12-31 | 13G | Athira Pharma, Inc. ATHA |
RTW Investments, LP | 2,685,779 8.260% |
16,866 (+0.63%) |
Filing History |
| 2021-02-08 5:16 pm Purchase |
2021-01-25 | 13D | Athira Pharma, Inc. ATHA |
PERCEPTIVE ADVISORS LLC | 3,425,916 9.800% |
3,425,916 (New Position) |
Filing History |
| 2020-11-16 4:05 pm Purchase |
2020-11-06 | 13G | Athira Pharma, Inc. ATHA |
Venrock Healthcare Capital Partners II, L.P. | 1,657,623 5.100% |
1,657,623 (New Position) |
Filing History |
| 2020-09-28 5:04 pm Purchase |
2020-09-18 | 13G | Athira Pharma, Inc. ATHA |
VIKING GLOBAL INVESTORS LP | 2,120,653 6.900% |
2,120,653 (New Position) |
Filing History |
| 2020-09-28 3:59 pm Purchase |
2020-09-18 | 13G | Athira Pharma, Inc. ATHA |
RTW Investments, LP | 2,668,913 8.660% |
2,668,913 (New Position) |
Filing History |